Light Pharma Incorporated – Trademark Portfolio
Entity Type: 03
Light Pharma Incorporated holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PI. The owner is based in Cambridge, MA.
One Broadway
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Light Pharma Incorporated's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Light Pharma Incorporated have?
Light Pharma Incorporated has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 3 cancelled.
What trademark classes does Light Pharma Incorporated file in?
Light Pharma Incorporated files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Light Pharma Incorporated's most well-known trademarks?
Light Pharma Incorporated's registered trademark portfolio includes well-known marks such as PI. These are among 1 currently registered trademark in the portfolio.
What is Light Pharma Incorporated's trademark registration success rate?
Light Pharma Incorporated has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.